Clinical Trial Update: Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma [NA]

View source ↗

Summary

A clinical trial comparing phacoemulsification with iStent Inject W versus Hydrus for mild to moderate open-angle glaucoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Hydrus Microstent
• iStent Inject W

Snippet

Sponsor: Diablo Eye Associates | Conditions: Open Angle Glaucoma | NA | Status: TERMINATED